Results 71 to 80 of about 645,718 (276)

Pertussis post-exposure prophylaxis among household contacts: a cost-utility analysis. [PDF]

open access: yes, 2015
BACKGROUND: Recent pertussis outbreaks have prompted re-examination of post-exposure prophylaxis (PEP) strategies, when immunization is not immediately protective.
Crowcroft, Natasha S   +3 more
core   +2 more sources

SPECIFIC PERTUSSIS PREVENTION: PROBLEMS AND PERSPECTIVES

open access: yesВопросы современной педиатрии, 2007
The lecture shows the modern state of the pertussis issue among the children. Based on the analysis of the presented data, the authors conclude that vaccination with the full cellular vaccine is rather safe; moreover, it protects the infants from the ...
S.M. Kharit   +3 more
doaj   +2 more sources

Shots at school? Public attitudes about vaccination services in school‐based health centers

open access: yesWorld Medical &Health Policy, Volume 17, Issue 1, Page 149-166, March 2025.
Abstract Vaccination rates have dropped across the United States. Vaccination hesitancy plays a major role in this development, but access barriers are also a contributing factor. Access barriers are particularly prevalent among marginalized populations.
Simon F. Haeder
wiley   +1 more source

COVID-19 Vaccine Hesitancy and Information Diffusion: An Agent-based Modeling Approach [PDF]

open access: yesarXiv, 2021
Despite the unprecedented success in the rapid development of several effective vaccines against the Cov-SARS-2, global vaccination rollout efforts suffer from vaccine distribution inequality and vaccine acceptance, leading to insufficient public immunity provided by the vaccine products.
arxiv  

Antenatal influenza and pertussis vaccination in Western Australia: a cross-sectional survey of vaccine uptake and influencing factors

open access: yesBMC Pregnancy and Childbirth, 2018
BackgroundInfluenza and pertussis vaccines have been recommended in Australia for women during each pregnancy since 2010 and 2015, respectively. Estimating vaccination coverage and identifying factors affecting uptake are important for improving ...
D. Mak, A. Regan, D. T. Vo, P. Effler
semanticscholar   +1 more source

What do Parents Learn by Reading a DPT Vaccine Information Form?

open access: yesCanadian Journal of Infectious Diseases, 1994
Objective: Information forms are commonly used to inform parents about childhood vaccination. This study assessed the knowledge of mothers about pertussis and pertussis vaccine before and after reading a form about diphtheria-pertussis-tetanus (dpt ...
Ronald Gold, Gordean L Bjornson
doaj   +1 more source

Disease Aggravation With Age in an Experimental Model of Multiple Sclerosis: Role of Immunosenescence

open access: yesAging Cell, Volume 24, Issue 5, May 2025.
Age‐related differences in EAE outcomes stem from combined peripheral and CNS factors. Key peripheral adaptive immunity changes include altered naïve/memory T cell ratios, Th1 skewing, increased suppressive Tregs, CD4+ T cell exhaustion, enhanced B cell antigen presentation, and reduced NK cell cytotoxicity.
María Dema   +6 more
wiley   +1 more source

Seroepidemiology of pertussis in Hangzhou, China, during 2009–2017

open access: yesHuman Vaccines & Immunotherapeutics, 2019
Objective: To delineate seroepidemiology of pertussis in Hangzhou, to evaluate the protection levels of pertussis among healthy populations, for improving prevention strategy of pertussis.Methods: During 2009–2017, a multistage stratified random sampling
Yuyang Xu   +10 more
doaj   +1 more source

Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis

open access: yesAllergy, EarlyView.
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller   +13 more
wiley   +1 more source

What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.

open access: yesPathogens and Disease, 2015
Pertussis (whooping cough) is a respiratory disease caused by the bacterium Bordetella pertussis. Despite the implementation of immunization programs and high vaccine coverage in most jurisdictions, pertussis is still one of the most common vaccine ...
S. Bolotin, E. Harvill, N. Crowcroft
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy